Journal: Acta physiologica (Oxford, England)
Article Title: PGC-1?4 gene expression is suppressed by the IL-6-MEK-ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury.
PMID/MRN: 27809412
Publication Date: 2016-Nov-03
Abstract:
PGC-1?4 is a novel regulator of muscle hypertrophy; however, there is limited understanding of the regulation of its expression and role in many (patho)physiological conditions. Therefore, our purpose was to elicit signalling mechanisms regulating gene expression of Pgc1?4 and examine its response to (patho)physiological stimuli associated with altered muscle mass.
IL-6 knockout mice and pharmacological experiments in C2C12 myocytes were used to identify regulation of Pgc1?4 transcription. To examine Pgc1?4 gene expression in (patho)physiological conditions, obese and lean Zucker rats with/without resistance exercise (RE), ageing mice and muscle regeneration from injury were examined.
In IL-6 knockout mice, Pgc1?4mRNA was ~sevenfold greater than wild type. In C2C12 cells, Pgc1?4mRNA was suppressed ~70% by IL-6. Suppression of Pgc1?4 by IL-6 was prevented by MEK-ERK-MAPK inhibition. RE led to ~260% greater Pgc1?4mRNA content in lean rats. However, obese Zucker rats exhibited ~270% greater Pgc1?4mRNA than lean, sedentary with no further augmentation by RE. No difference was seen in IL-6mRNA or ERK-MAPK phosphorylation in Zucker rats. Aged mice demonstrated ~50% lower Pgc1?4mRNA and ~fivefold greater ERK-MAPK phosphorylation than young despite unchanged Il-6mRNA. During muscle regeneration, Pgc1?4 content is ~30% and IL-6mRNA >threefold of uninjured controls 3Ędays following injury; at 5Ędays, Pgc1?4 was >twofold greater in injured mice with no difference in IL-6mRNA.
Our findings reveal a novel mechanism suppressing Pgc1?4 gene expression via IL-6-ERK-MAPK and suggest this signalling axis may inhibit Pgc1?4 in some, but not all, (patho)physiological conditions.
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.